Trials / Not Yet Recruiting
Not Yet RecruitingNCT06646796
Yoga Impact in Fibromyalgia, Primary Health Care
Fibromyalgia: Impact on Pain, Quality of Life of a Complementary Therapy on Primary Health Care
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Coimbra · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effectiveness of a complementary therapy using Yoga within the scope of First Health Care in Portugal, in pain control, quality of life and well-being of the patients with Fibromyalgia. It also, pretends to assess the viability and to identify the barriers to this sort of therapy in the context of Primary Health Care.
Detailed description
Fibromyalgia is a chronic and debilitating pain syndrome characterized by widespread and persistent pain, also affecting sleep quality and cognitive function. It is estimated to affect 3.6% of the population; however, since it is a condition that is often underdiagnosed, the actual numbers may be higher. It is also an incurable disease, so treatment is based on symptom management through pharmacological therapy, which is not always effective. Due to the inadequacy of pharmacological therapy, there is a need for complementary therapies, and despite the limited number of studies conducted in this area, some therapies based on meditative movement (notably yoga) are beginning to emerge, with beneficial effects reported on pain management and quality of life in these patients. Therefore, this study aims to investigate the benefits and feasibility of this type of intervention at the Primary Health Care level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Yoga | Yoga with certified teacher, 3 times a week during 3 months. |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2025-02-28
- Completion
- 2025-04-30
- First posted
- 2024-10-17
- Last updated
- 2024-10-17
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT06646796. Inclusion in this directory is not an endorsement.